What ever happened to N-of-1 trials? Insiders' perspectives and a look to the future

Milbank Quarterly

Volumn 86, Issue 4, 2008, Pages 533-555

  Kravitz, Richard L ^a,b   Duan, Naihua ^c   Niedzinski, Edmund J ^c   Hay, M Cameron ^c   Subramanian, Saskia K ^c   Weisner, Thomas S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

Bayesian methods; Clinical effectiveness; N of 1 trial; Personalized medicine; Research policy; Treatment effects heterogeneity

Indexed keywords

ARTICLE; BAYES THEOREM; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HUMAN; METHODOLOGY; QUESTIONNAIRE; TELEPHONE;

BAYES THEOREM; CLINICAL TRIALS AS TOPIC; DELIVERY OF HEALTH CARE; EVIDENCE-BASED MEDICINE; HUMANS; QUESTIONNAIRES; TELEPHONE;

EID: 56649123410     PISSN: 0887378X     EISSN: 14680009     Source Type: Journal    
DOI: 10.1111/j.1468-0009.2008.00533.x     Document Type: Article

References (41)

1. Barlow, D.H., and M. Hersen. 1984. Single Case Experimental Designs: Strategies for Studying Behavior Change. 2nd ed. New York : Pergamon Press.
2. Benson, H., and R. Friedman. 1996. Harnessing the Power of the Placebo Effect and Renaming It "Remembered Wellness." Annual Review of Medicine 47 : 193 99.
3. Bodenheimer, T. 1999. The American Health Care System - Physicians and the Changing Medical Marketplace. New England Journal of Medicine 340 : 584 88.
4. Bodenheimer, T. 2006. Primary Care - Will It Survive New England Journal of Medicine 355 : 861 64.
5. Brookes, S.T., L. Biddle, C. Paterson, G. Woolhead, and P. Dieppe. 2007 Me's Me and You's You": Exploring Patients' Perspectives of Single Patient (N-of-1) Trials in the UK. Trials 8:10.
6. Frank, R.G., R. Zeckhauser, and National Bureau of Economic Research. 2007. Custom Made versus Ready to Wear Treatments; Behavioral Propensities in Physicians' Choices. Cambridge, Mass National Bureau of Economic Research.
7. Green, L.A., and J. Hickner. 2006. A Short History of Primary Care Practice-Based Research Networks: From Concept to Essential Research Laboratories. Journal of the American Board of Family Medicine 19 : 1 10.
8. Greenfield, S., R. Kravitz, N. Duan, and S.H. Kaplan. 2007. Heterogeneity of Treatment Effects: Implications for Guidelines, Payment, and Quality Assessment. American Journal of Medicine 120 : S3 9.
9. Guyatt, G.H., A. Heyting, R. Jaeschke, J. Keller, J.D. Adachi, and R.S. Roberts. 1990a. N of 1 Randomized Trials for Investigating New Drugs. Controlled Clinical Trials 11 : 88 100.
10. Guyatt, G.H., J.L. Keller, R. Jaeschke, D. Rosenbloom, J.D. Adachi, and M.T. Newhouse. 1990b. The N-of-1 Randomized Controlled Trial: Clinical Usefulness. Our Three-Year Experience. Annals of Internal Medicine 112 : 293 99.
11. Guyatt, G.H., D. Sackett, J. Adachi, R. Roberts, J. Chong, D. Rosenbloom, and J. Keller. 1988. A Clinician's Guide for Conducting Randomized Trials in Individual Patients. Canadian Medical Association Journal 139 : 497 503.
12. Guyatt, G.H., D. Sackett, D.W. Taylor, J. Chong, R. Roberts, and S. Pugsley. 1986. Determining Optimal Therapy - Randomized Trials in Individual Patients. New England Journal of Medicine 314 : 889 92.
13. Hochberg, M.C., J.K. Tracy, and R.H. Flores. 2001 Stepping-Up" from Methotrexate: A Systematic Review of Randomised Placebo Controlled Trials in Patients with Rheumatoid Arthritis with an Incomplete Response to Methotrexate. Annals of the Rheumatic Diseases 60 (suppl. 3 iii51 54.
14. Hoffman, E.P. 2007. Skipping toward Personalized Molecular Medicine. New England Journal of Medicine 357 : 2719 22.
15. Kazdin, A.E. 1982. Single-Case Research Designs: Methods for Clinical and Applied Settings. New York : Oxford University Press.
16. Kratochwill, T.R. 1978. Single Subject Research: Strategies for Evaluating Change. New York : Academic Press.
17. Kravitz, R.L., N. Duan, and J. Braslow. 2004. Evidence-Based Medicine, Heterogeneity of Treatment Effects, and the Trouble with Averages. The Milbank Quarterly 82 : 661 87.
18. Kravitz, R.L., N. Duan, and R.H. White. 2008. N-of-1 Trials of Expensive Biological Therapies: A Third Way Archives of Internal Medicine 168 : 1030 33.
19. Larson, E.B., A.J. Ellsworth, and J. Oas. 1993. Randomized Clinical Trials in Single Patients during a 2-Year Period. Journal of the American Medical Association 270 : 2708 12.
20. Makoul, G., and M.L. Clayman. 2006. An Integrative Model of Shared Decision Making in Medical Encounters. Patient Education and Counseling 60 : 301 12.
21. Nikles, C.J., A.M. Clavarino, and C.B. Del Mar. 2005. Using N-of-1 Trials as a Clinical Tool to Improve Prescribing. British Journal of General Practice 55 : 175 80.
22. Nikles, C.J., P.P. Glasziou, C.B. Del Mar, C.M. Duggan, A. Clavarino, and M.J. Yelland. 2000a. Preliminary Experiences with a Single-Patient Trials Service in General Practice. Medical Journal of Australia 173 : 100 103.
23. Nikles, C.J., P.P. Glasziou, C.B. Del Mar, C.M. Duggan, and G. Mitchell. 2000b. N of 1 Trials. Practical Tools for Medication Management. Australian Family Physician 29 : 1108 12.
24. Nikles, C.J., G.K. Mitchell, C.B. Del Mar, A. Clavarino, and N. McNairn. 2006. An N-of-1 Trial Service in Clinical Practice: Testing the Effectiveness of Stimulants for Attention-Deficit/Hyperactivity Disorder. Pediatrics 117 : 2040 46.
25. Nikles, C.J., M. Yelland, P.P. Glasziou, and C. Del Mar. 2005. Do Individualized Medication Effectiveness Tests (N-of-1 Trials) Change Clinical Decisions about Which Drugs to Use for Osteoarthritis and Chronic Pain American Journal of Therapeutics 12 : 92 97.
26. Reitberg, D.P. 2001. Method and Kit for Treating Illness. Edited by USPTO. USA : Opt-e-Scrip.
27. Reitberg, D.P. 2003. Method and Kit for Treating Illnesses. Edited by USPTO. USA : Opt-e-Scrip.
28. Rich, S.R., I.C. Coleman, R. Cook, D.S. Hum, B. Johnson, T. Maves, W.J. Mazanec, J.R. Miller, W.J. Proveaux, H.S. Rossman, and W.H. Stuart. 2004. Stepped-Care Approach to Treating MS: A Managed Care Treatment Algorithm. Journal of Managed Care Pharmacy 10 : S26 32.
29. Rogers, E.M. 2003. Diffusion of Innovations. 5th ed. New York : Free Press
30. Schluter, P., and R. Ware. 2005. Single Patient (N-of-1) Trials with Binary Treatment Preference. Statistics Medicine 24 : 2625 36.
31. Schwartz, L.M., S. Woloshin, and H.G. Welch. 2007. The Drug Facts Box: Providing Consumers with Simple Tabular Data on Drug Benefit and Harm. Medical Decision Making 27 : 655 62.
32. Senn, S.J. 1991. Controlled Trials in Single Subjects. British Medical Journal 303 : 716 17.
33. Senn, S.J. 1993. Suspended Judgment N-of-1 Trials. Controlled Clinical Trials 14 : 1 5.
34. Senn, S.J. 1998. Applying Results of Randomised Trials to Patients. N of 1 Trials Are Needed. British Medical Journal 317 : 537 38.
35. Senn, S.J. 2001. Individual Therapy: New Dawn or False Dawn. Drug Information Journal 35 : 1479 94.
36. Senn, S.J. 2003. Author's Reply to Walter and Guyatt. Drug Information Journal 35 : 1479 94.
37. Senn, S.J., R. Bakshi, and N. Ezzet. 1995. N of 1 Trials in Osteoarthritis. Caution in Interpretation Needed. British Medical Journal 310 : 667.
38. Sidman, M. 1960. Tactics of Scientific Research; Evaluating Experimental Data in Psychology. New York : Basic Books.
39. Walter, L.C., N.P. Davidowitz, P.A. Heineken, and K.E. Covinsky. 2004. Pitfalls of Converting Practice Guidelines into Quality Measures: Lessons Learned from a VA Performance Measure. Journal of the American Medical Association 291 : 2466 70.
40. Wilkes, M.S., R.A. Bell, and R.L. Kravitz. 2000. Direct-to-Consumer Prescription Drug Advertising: Trends, Impact, and Implications. Health Affairs 19 : 110 28.
41. Zucker, D., C. Schmid, M. McIntosh, R. D'Agostino, H. Selker, and J. Lau. 1997. Combining Single Patient (N-of-1) Trials to Estimate Population Treatment Effects and to Evaluate Individual Patient Responses to Treatment. Journal of Clinical Epidemiology 50 : 401 10.